Hikma Pharmaceutical | HIK - 営業経費





営業経費 変化する 日付
Almirall EUR 531.16M 13.76M 2026-06
argenx SE USD 1.02B 118M 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Autolus Therapeutics Ltd USD 85.73M 11.02M 2026-03
Bayer EUR 10.04B 168M 2026-06
Fresenius EUR 5.23B 9M 2026-06
Genmab DKK 748M 77M 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Orion EUR 345M 42.1M 2026-06
Recordati EUR 493.59M 11.28M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
UCB EUR 2.96B 196M 2025-12